DrugCite
Search

AKINETON

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Akineton Adverse Events Reported to the FDA Over Time

How are Akineton adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Akineton, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Akineton is flagged as the suspect drug causing the adverse event.

Most Common Akineton Adverse Events Reported to the FDA

What are the most common Akineton adverse events reported to the FDA?

Neuroleptic Malignant Syndrome
112 (2.53%)
Delirium
96 (2.17%)
Suicide Attempt
88 (1.99%)
Somnolence
68 (1.54%)
Overdose
59 (1.33%)
Confusional State
49 (1.11%)
Coma
48 (1.09%)
Self Injurious Behaviour
47 (1.06%)
Multiple Drug Overdose Intentional
45 (1.02%)
Tremor
45 (1.02%)
Tachycardia
42 (.95%)
Show More Show More
Drug Interaction
39 (.88%)
Pyrexia
38 (.86%)
Blood Creatine Phosphokinase Increa...
37 (.84%)
Agitation
36 (.81%)
Disorientation
36 (.81%)
Insomnia
36 (.81%)
Rhabdomyolysis
36 (.81%)
Fatigue
34 (.77%)
Drug Exposure During Pregnancy
32 (.72%)
Fall
32 (.72%)
Hallucination
32 (.72%)
Restlessness
32 (.72%)
Depressed Level Of Consciousness
30 (.68%)
Dyspnoea
30 (.68%)
Mydriasis
30 (.68%)
Extrapyramidal Disorder
29 (.66%)
Pneumonia
29 (.66%)
Convulsion
28 (.63%)
Hyponatraemia
28 (.63%)
Loss Of Consciousness
28 (.63%)
Drug Ineffective
27 (.61%)
Hypotension
27 (.61%)
Vomiting
26 (.59%)
Alanine Aminotransferase Increased
25 (.57%)
Aspartate Aminotransferase Increase...
24 (.54%)
Dysphagia
24 (.54%)
Asthenia
22 (.5%)
Renal Failure Acute
22 (.5%)
Urinary Retention
22 (.5%)
Altered State Of Consciousness
21 (.48%)
Condition Aggravated
21 (.48%)
Ileus
21 (.48%)
Parkinsonism
21 (.48%)
Schizophrenia
21 (.48%)
Thrombocytopenia
21 (.48%)
Intentional Overdose
19 (.43%)
Liver Disorder
19 (.43%)
Psychotic Disorder
19 (.43%)
Sopor
18 (.41%)
Aggression
17 (.38%)
Anaemia
17 (.38%)
Blood Lactate Dehydrogenase Increas...
17 (.38%)
Cardio-respiratory Arrest
17 (.38%)
Completed Suicide
17 (.38%)
Gait Disturbance
17 (.38%)
Hallucination, Visual
17 (.38%)
Malaise
17 (.38%)
Memory Impairment
17 (.38%)
Abnormal Behaviour
16 (.36%)
Acute Hepatic Failure
16 (.36%)
Constipation
16 (.36%)
Multiple Drug Overdose
16 (.36%)
Blood Creatinine Increased
15 (.34%)
Cognitive Disorder
15 (.34%)
Ileus Paralytic
15 (.34%)
Nausea
15 (.34%)
Anxiety
14 (.32%)
Blood Alkaline Phosphatase Increase...
14 (.32%)
Bradycardia
14 (.32%)
Depression
14 (.32%)
Pain
14 (.32%)
Sedation
14 (.32%)
Blood Glucose Increased
13 (.29%)
Dizziness
13 (.29%)
Dyskinesia
13 (.29%)
Muscle Rigidity
13 (.29%)
Pulmonary Embolism
13 (.29%)
Respiratory Failure
13 (.29%)
Tardive Dyskinesia
13 (.29%)
Dehydration
12 (.27%)
Hepatitis Acute
12 (.27%)
Intra-uterine Death
12 (.27%)
Oedema Peripheral
12 (.27%)
Pneumonia Aspiration
12 (.27%)
Speech Disorder
12 (.27%)
Urinary Incontinence
12 (.27%)
Activities Of Daily Living Impaired
11 (.25%)
Amnesia
11 (.25%)
Cardiac Failure
11 (.25%)
Gastrointestinal Disorder
11 (.25%)
Sleep Disorder
11 (.25%)
Apathy
10 (.23%)
Back Pain
10 (.23%)
Blood Pressure Increased
10 (.23%)
Cardiac Arrest
10 (.23%)
Diabetes Mellitus
10 (.23%)
Dysarthria
10 (.23%)
Feeling Abnormal
10 (.23%)
Hallucination, Auditory
10 (.23%)
Hepatitis
10 (.23%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Akineton, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Akineton is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Akineton

What are the most common Akineton adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Akineton, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Akineton is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Akineton According to Those Reporting Adverse Events

Why are people taking Akineton, according to those reporting adverse events to the FDA?

Drug Use For Unknown Indication
298
Product Used For Unknown Indication
203
Parkinsonism
161
Schizophrenia
159
Extrapyramidal Disorder
139
Parkinsons Disease
113
Show More Show More
Prophylaxis
69
Depression
51
Akathisia
41
Suicide Attempt
35
Tremor
35
Schizophrenia, Paranoid Type
25
Bipolar I Disorder
21
Psychotic Disorder
16
Ill-defined Disorder
14
Bipolar Disorder
11
Delirium
11
Self Injurious Behaviour
11
Dyskinesia
11
Drug Exposure During Pregnancy
10
Salivary Hypersecretion
9
Dystonia
9
Mental Disorder
9
Alcoholic Psychosis
8
Intentional Overdose
8
Movement Disorder
8
Insomnia
8
Mania
8
Irritability
5
Hypokinesia
5
Acute Psychosis
5
Accidental Exposure
5
Muscle Rigidity
4
Alcohol Withdrawal Syndrome
4
Autism
4
Hypertension
3
Sedative Therapy
3
Adverse Event
3
Pleurothotonus
3
Thirst
3
Anticholinergic Syndrome
3
Catatonia
3
Agitation
3
Intentional Self-injury
3
Cerebrovascular Accident
3
Schizoaffective Disorder
3
Dementia Alzheimers Type
2
Parkinsonian Gait
2
Muscle Spasms
2
Anxiety
2
Dementia
2

Akineton Case Reports

What Akineton safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Akineton. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Akineton.